Small cell lung cancer extensive stage – Diagnostics – Overview of Information and Clinical Research

Finding out whether you have extensive stage small cell lung cancer requires a series of careful tests and examinations. Understanding these diagnostic steps can help you prepare for what lies ahead and work more effectively with your healthcare team to determine the best path forward.

Introduction: Who Should Seek Diagnostics

If you smoke, used to smoke, or have been exposed to secondhand smoke for a long time, and you notice certain warning signs, it’s important to talk with a healthcare provider as soon as possible. Small cell lung cancer that hasn’t spread often doesn’t cause symptoms in its early stages, which is why many people don’t discover they have the disease until it has already progressed to a more advanced state.^[2]

You should consider seeking medical evaluation if you experience symptoms such as a chronic cough that doesn’t go away or gets worse over time, coughing up blood, chest pain or discomfort, difficulty breathing, wheezing, hoarseness, unexplained weight loss, loss of appetite, extreme tiredness, facial swelling, or swollen neck veins.^[2] Many of these symptoms can be caused by conditions far less serious than cancer, so having one or more of these signs doesn’t automatically mean you have small cell lung cancer. However, because this type of cancer grows and spreads rapidly, early detection through proper diagnostic testing can make a significant difference in treatment options and outcomes.^[2]

People who are current smokers or who quit within the past 15 years may benefit from screening to detect small cell lung cancer before symptoms appear.^[14] This is especially important because extensive stage small cell lung cancer is often discovered when cancer has already spread, partly because early disease rarely produces noticeable symptoms.

⚠️ Important

About two-thirds of people diagnosed with small cell lung cancer already have extensive stage disease at the time they receive their diagnosis.^[6] This happens because the cancer grows quickly and spreads early, often before symptoms become noticeable. If you have risk factors such as a smoking history and develop any concerning symptoms, don’t wait to seek medical attention.

Classic Diagnostic Methods

Diagnosing extensive stage small cell lung cancer involves several types of tests and procedures. Your healthcare provider will likely start with a review of your medical history and a physical examination, then move on to more specialized testing. The goal is not only to confirm whether cancer is present, but also to understand how far it has spread throughout your body.^[7]

Imaging Tests

Imaging tests create pictures of the inside of your body and are essential tools for detecting lung cancer and determining its extent. Computed tomography (CT) scans use X-rays to create detailed cross-sectional images of your chest and abdomen. These scans can show the size and location of tumors, as well as whether cancer has spread to nearby lymph nodes or other organs.^[7] For small cell lung cancer, contrast-enhanced CT scans of the chest and abdomen have traditionally been part of the standard staging workup.^[7]

Magnetic resonance imaging (MRI) scans use powerful magnets and radio waves instead of X-rays to create detailed images. MRI is particularly useful for examining the brain to check whether small cell lung cancer has spread there, which is common with this type of cancer.^[7] Your doctor might recommend a brain MRI or CT scan as part of your initial evaluation.^[7]

Positron emission tomography (PET) scans have become increasingly important in diagnosing and staging small cell lung cancer. During a PET scan, a small amount of radioactive sugar is injected into your body. Cancer cells, which use more energy than normal cells, absorb more of this sugar and light up on the scan. Recent research suggests that PET scanning can improve both the accuracy of staging and treatment planning for patients with small cell lung cancer.^[7]

A bone scan uses a different type of radioactive material to detect whether cancer has spread to your bones. This test has traditionally been included in the standard staging workup for small cell lung cancer.^[7] The radioactive material collects in areas of bone where cancer cells are present, making them visible on the scan images.

Simple chest X-rays might be used initially if you have symptoms, but they cannot provide enough detail to determine the stage of cancer or see small tumors, so more advanced imaging is usually needed.^[2]

Tissue and Fluid Sampling

While imaging tests can show suspicious areas, a biopsy is the only way to confirm with certainty that you have lung cancer. A biopsy involves removing a small sample of tissue so it can be examined under a microscope by a specialist.^[18] There are several ways to obtain a biopsy sample from the lungs.

Bronchoscopy is a procedure where a thin, flexible tube with a light and camera is passed through your nose or mouth, down your throat, and into your airways. The doctor can look directly at the inside of your airways and take small tissue samples from suspicious areas.^[7] This procedure is often performed with sedation to keep you comfortable.

Fine needle aspiration uses a thin needle inserted through your chest wall to remove cells from a suspicious lung mass. This is often done with CT scan guidance to help the doctor position the needle accurately.^[7] The procedure is generally done with local numbing medicine.

If fluid has built up around your lungs (a condition called pleural effusion), your doctor might perform a thoracentesis.^[7] During this procedure, a needle is inserted between your ribs to remove some of the fluid. The fluid is then examined for cancer cells. The presence of cancer cells in this fluid typically indicates extensive stage disease.^[1]

Sputum cytology involves examining mucus that you cough up from your lungs under a microscope to look for cancer cells.^[7] However, this test alone is not sufficient to diagnose or stage small cell lung cancer.

Laboratory Tests

Blood tests are routinely performed as part of the diagnostic process. While blood tests alone cannot diagnose small cell lung cancer, they provide important information about your overall health and how well your organs are functioning. This information helps your healthcare team understand whether your body is strong enough for certain treatments and whether cancer may have affected organs like your liver or kidneys.^[2]

Some blood tests check for specific substances that might be elevated when cancer is present, though these are not used to make a diagnosis of small cell lung cancer itself. Laboratory analysis of biopsy samples can confirm the type of lung cancer by examining how the cells look under a microscope. Small cell lung cancer cells are described as being smaller than normal cells and often round, oval, or spindle-shaped.^[18]

Understanding Staging Systems

Once small cell lung cancer is diagnosed, doctors need to determine its stage, meaning how much cancer is present and where it has spread. For small cell lung cancer, doctors have traditionally used a simpler system than for other types of cancer. This system divides the disease into two main stages: limited disease and extensive disease.^[1]

Limited disease means the cancer is contained in a single area on one side of the chest where it can be treated with radiation therapy directed to just one area. This generally means the cancer is only in one lung and may be in nearby lymph nodes, such as those in the center of the chest or above the collarbone.^[1]

Extensive disease means the cancer has spread beyond a single area that can be treated with radiation to one location. It might have spread within the chest to the other lung or to lymph nodes farther away from the cancer, to other parts of your body, or into the space between the layers of tissue surrounding the lungs, causing fluid buildup.^[1] Cancer might also spread between the heart and the sack that surrounds it, causing fluid accumulation there.^[1]

More recently, doctors are also using the TNM staging system along with the limited/extensive classification. TNM stands for Tumor, Node, and Metastasis. This system looks at the size of the tumor (T), whether cancer has spread to lymph nodes (N), and whether it has spread to distant parts of the body (M).^[1] In the TNM system, extensive disease corresponds roughly to stage 4 cancer.^[1] The American Joint Committee on Cancer now recommends using the TNM system for staging small cell lung cancer, and many doctors use both systems together.^[1]

Doctors may consider small cell lung cancer to be extensive if it has spread widely throughout one lung, to both lungs, to lymph nodes on the opposite side of the chest, to fluid surrounding the lungs, or to other parts of the body such as the brain, liver, bones, or adrenal glands.^[6] Small cell lung cancer typically spreads to lymph nodes, bones, brain, liver, and adrenal glands.^[2]

Diagnostics for Clinical Trial Qualification

If you are considering participating in a clinical trial for extensive stage small cell lung cancer, you will likely need to undergo specific diagnostic tests to determine whether you qualify. Clinical trials have strict eligibility requirements to ensure that participants are appropriate for the experimental treatment being studied and that researchers can accurately measure the treatment’s effects.

Clinical trials typically require confirmation of your diagnosis through biopsy results showing small cell lung cancer. You will need imaging studies, usually including CT scans and possibly PET scans, to document the location and extent of your cancer.^[7] These baseline images are essential because researchers will compare them to images taken during and after treatment to see whether the experimental therapy is working.

Many clinical trials require specific tests to assess your overall health and organ function. Blood tests checking your liver function, kidney function, and blood cell counts are commonly required. These tests help ensure that you are healthy enough to tolerate the experimental treatment and that the treatment won’t cause dangerous complications due to underlying organ problems.^[12]

Depending on the type of treatment being studied, you might need additional specialized testing. For example, clinical trials studying immunotherapy drugs might require testing of your tumor tissue for specific markers that predict how well the treatment might work. Some trials studying targeted therapies require testing for specific genetic changes or proteins in your cancer cells.

In recent years, researchers have been working to identify biomarkers that might predict which patients will respond best to certain treatments for small cell lung cancer. A biomarker is a measurable substance in your body that indicates the presence of disease or how a disease might behave. For small cell lung cancer, testing might look for specific genetic mutations such as TP53 and RB1, which are commonly found in this cancer.^[18]

However, unlike non-small cell lung cancer where biomarker testing has led to many targeted treatments, effective targeted therapies for small cell lung cancer are still being developed. Currently, biomarker testing is not routinely recommended for all small cell lung cancer patients outside of clinical trials, though this is an active area of research.^[18] If you enroll in a clinical trial, the researchers may test your tumor for various biomarkers to learn more about the disease and potentially identify which patients benefit most from the treatment being studied.

⚠️ Important

Because small cell lung cancer is relatively rare and highly aggressive, it is especially important to seek care at a major cancer center that has experience treating this type of lung cancer.^[14] These centers often have access to clinical trials that may offer promising new treatment options not yet widely available. They also have specialists who understand the different molecular characteristics of small cell lung cancer and can design more effective, personalized treatments.^[14]

Performance status assessment is another important part of qualifying for clinical trials. Your doctor will evaluate how well you can perform daily activities and how much the cancer is affecting your physical functioning. This assessment, often called ECOG performance status or Karnofsky performance status, helps determine whether you are strong enough for intensive treatments being tested in clinical trials.^[12]

Some clinical trials for extensive stage small cell lung cancer require that patients have not yet received any treatment for their cancer, while others specifically enroll patients whose cancer has progressed after initial treatment. Understanding which category you fall into will help you and your doctor identify appropriate clinical trials to consider.

Prognosis and Survival Rate

Prognosis

The outlook for people with extensive stage small cell lung cancer depends on many factors. This type of cancer is very aggressive and grows rapidly, which makes it challenging to treat.^[6] There is currently no cure for extensive stage small cell lung cancer, though treatments can help people live longer and maintain a better quality of life.^[6] Healthcare providers can cure some people if small cell lung cancer is found very early, but for those with extensive stage disease, the goal of treatment is to slow the cancer’s progression, reduce symptoms, and extend life as much as possible.^[2]

Several factors affect your prognosis. Your age and overall health play important roles in determining how well you might tolerate treatment and respond to it. How well your body’s organs are functioning, particularly your heart, lungs, liver, and kidneys, influences treatment options and outcomes. Your performance status, meaning how well you can carry out daily activities, is another important consideration.^[12]

Most people with extensive stage small cell lung cancer initially respond well to chemotherapy, with more than half of patients showing improvement.^[3] However, the cancer typically returns after treatment, and when it comes back, it often responds poorly to subsequent therapies.^[3] The cancer may become resistant to treatments that previously helped, presenting ongoing challenges for patients and their healthcare teams.^[6]

Recent advances in treatment, particularly the addition of immunotherapy drugs to chemotherapy, have improved outcomes for some patients with extensive stage small cell lung cancer. New treatments approved in recent years include drugs like atezolizumab, durvalumab, and others that work with your immune system to fight cancer.^[3] Newer immunotherapy drugs called bispecific T-cell engagers, such as tarlatamab, have shown that about 40% of people who receive the drug can expect their tumors to shrink.^[14]

Survival rate

Survival statistics for extensive stage small cell lung cancer show the serious nature of this disease. On average, patients with extensive stage small cell lung cancer live for about 7 months.^[20] However, it’s crucial to understand that averages don’t tell the whole story, and individual experiences can vary significantly. Some patients have lived for many years, even decades, thanks to the treatments they received.^[20]

Although most patients with extensive stage disease rarely survive beyond one year without treatment, medical advances continue to improve these outcomes.^[3] The development of new therapies, particularly immunotherapy drugs and targeted treatments being tested in clinical trials, offers hope for continued progress in extending survival times and improving quality of life for patients with extensive stage small cell lung cancer.^[14]

It’s important to remember that survival statistics are based on large groups of people and represent averages from past years. They cannot predict what will happen to any individual person. Your personal outcome depends on many factors unique to your situation, including your specific cancer characteristics, your overall health, how you respond to treatment, and what new treatments become available. Many people with extensive stage small cell lung cancer are living longer than past statistics would suggest, thanks to improvements in care and new treatment options.^[14]